HomeAbout usTeamInvestor relationsPress releasesMediaCedar PsychiatryCedar Clinical ResearchCareersFAQContact
Novamind and Wholeness Center partner on a psychedelic therapy protocol for frontline healthcare workers

Group ketamine therapy for healthcare workers with Covid-based stress & trauma led by Dr. Scott Shannon and Dr. Reid Robison

Learn more

Press releases

September 14, 2021

Novamind to Present at Life Sciences Investor Forum

September 13, 2021

Novamind to Serve as Research Site for Karuna Therapeutics Late-Stage Clinical Trial

September 09, 2021

Novamind Uplists to OTCQB Venture Market

September 08, 2021

Novamind to Present at H.C. Wainwright 23rd Annual Global Investment Conference

August 11, 2021

Novamind Divests Non-Core Retreat Investment

August 06, 2021

Novamind Strengthens Mental Health Expertise, Adds Communications Leader

July 29, 2021

Novamind Opens 5th Location Specialized in Integrative Psychiatry for Patients with Treatment-Resistant Conditions

July 21, 2021

Novamind Has Applied to Have its Common Shares Posted for Trading on the OTCQB in the United States

July 08, 2021

Novamind Selected as Research Site for Bionomics’ PTSD Clinical Trial

June 30, 2021

Novamind Launches Psychedelic Therapy Frontiers Podcast

Sign up for our newsletter

Get our latest press releases and round ups of Novamind news and media delivered right to your inbox.